This study investigates the use of pancreatic radiofrequency for treating pancreatic tumors. The purpose of this study is to evaluate the treatment's effectiveness five years after completion.
The study focuses on assessing the oncological outcomes of the pancreatic radiofrequency procedure. It evaluates the response rate to determine the treatment's safety and effectiveness.
- Who can participate: Adults aged 18 and older with a pancreatic tumor suitable for ultrasound-guided radiofrequency treatment can participate.
- Study details: Participants will undergo pancreatic radiofrequency treatment using a fine needle guided by ultrasound. The study includes follow-up visits to evaluate the treatment's effectiveness.
- Study timelines and visits: The study will last 5 years. The study requires 7 visits.
How understandable was the trial content above?
Hard to understand
Easy to understand